BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Pharm Country

  SOSV-backed Biotech Firm Cell BioEngines Decides New York Is the Place to BeCell BioEngines, Inc moves to Manhattan, New York, to leverage the city’s focus and strategic investment in biotech

  Cell BioEngines, Inc., founded by visionary Dr. Ajay Vishwakarma aiming to turn cancer into a curable disease announced that the SOSV-backed company will establish its executive headquarters in NYC, a hub for the fast-growing life-science ecosystem across New York state.

  January 13, 2024

   · 

  2 min read
• Policy

  Drug Farm Receives Rare Pediatric Disease Designation from the U.S. FDA for DF-003 to Treat ROSAH Syndrome

  Drug Farm, a clinical-stage biopharmaceutical company announced that the U.S. Food and Drug Administration has granted Rare Pediatric Disease Designation for the company’s alpha-kinase 1 inhibitor, DF-003, to treat patients with ROSAH Syndrome.

  January 13, 2024

   · 

  3 min read